Company intelligence / Profile preview

Hongkong Rongxin Bio-Tech

Xi'an, Shaanxi, China/Hong Kong SAR6sense.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Hongkong Rongxin Bio-Tech is a manufacturer and global distributor of pharmaceutical-grade steroid hormones, peptide hormones, APIs, and intermediates. The company operates GMP-compliant facilities and exports to multiple regions worldwide. Its products are primarily used in bodybuilding, hormone replacement therapy, weight management, and some cancer-related applications. No clinical trial data or regulatory approvals for finished pharmaceuticals are reported.

Therapeutic areas: Men's HealthMetabolic DisordersOncologyEndocrinology
Modalities: Small moleculePeptidesProtein
Industry: Contract Manufacturing Organization

Partnerships

None specifically listed; works with global distributors

Beyond the preview

Go deeper on Hongkong Rongxin Bio-Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hongkong Rongxin Bio-Tech.

Explore the full profile